Premier Explosives Limited announces an acquisition

The timeline was revised primarily because CCI approval was still pending—not because SEBI identified a substantive defect in the open-offer terms. Apollo Micro Systems had requested additional time to complete the offer formalities and sought a waiver of interest otherwise payable on the offer price while awaiting Competition Commission of India approval. ^[1]

What SEBI required

• Approval dependency: The Tendering Period must commence no later than 12 working days from the date CCI approval is received. ^[2]
• Payment compliance: Shareholders whose shares are accepted must be paid within 10 working days after the last day of the Tendering Period. ^[2]
• Delay consequence: Apollo remains liable to pay interest at 10% per annum for any delay in making that payment; SEBI did not grant the requested interest waiver. ^[1]
• Disclosure compliance: Premier Explosives was directed to disseminate SEBI’s letter immediately under Regulation 30 of the SEBI LODR Regulations and make the necessary disclosures. ^[3]

Thus, the cited procedural gap was the inability to proceed within the previously planned schedule because the required CCI approval had not yet been obtained. The directive does not identify a separate deficiency in the offer price, share entitlement or Letter of Offer.

Effect on the Tendering Period dates

Implication: If CCI approval is received after the original planned start date, the Tendering Period will move correspondingly, and the payment deadline will also move to 10 working days after the revised closing date. The exact revised calendar dates cannot be determined without the CCI approval date and a formal updated schedule.

Yes. SEBI’s directive makes payment of interest at 10% per annum a condition for the delay in completing the open offer. The tendering period must begin within 12 working days of CCI approval, and payment to shareholders whose shares are accepted must be made within 10 working days after the tendering period closes; the acquirer must pay interest for the delayed period. ^[2]

Estimated liability

The offer covers up to 1,39,77,911 shares at INR 698 per share. ^[2]

• Maximum offer consideration: 1,39,77,911 × INR 698 = INR 9,756,581,878, or approximately Rs 97.57 Crores.
• Annual interest at 10%: approximately Rs 9.76 Crores.
• Indicative interest for a 12-day delay: Rs 97.57 Crores × 10% × 12/365 = approximately Rs 0.32 Crores, or Rs 32.08 lakh.

This Rs 32 lakh estimate assumes full acceptance and treats the revised 12-working-day period as the interest-bearing delay using a 365-day convention. The actual liability could differ because the disclosure does not provide the CCI approval date, the original scheduled payment date, the precise number of calendar days of delay, or the final number of shares accepted. The incremental cost is approximately Rs 2.67 lakh per calendar day for every additional day of delay, assuming full acceptance. SEBI’s letter-of-offer framework also provides for interest on accepted shares for delays beyond the prescribed payment timeline under Regulations 18(11) and 18(11A) of the SAST Regulations. ^[5]

CCI approval is the only specifically identified outstanding regulatory clearance, and it is the primary documented bottleneck. As of the 17 August request referenced in SEBI’s 21 August communication, Apollo Micro Systems had not received CCI approval and sought additional time to proceed with the open-offer formalities. ^[1]

• CCI: Pending in the latest disclosure. SEBI has linked commencement of the tendering period directly to the date of CCI approval; the offer must start within 12 working days of that approval. ^[2]
• Other statutory or regulatory clearances: The transaction disclosure says completion is conditional on CCI approval, other conditions precedent under the SPA, SEBI SAST compliance and the mandatory open offer. ^[6]
• MHA approval: No specific MHA approval is identified or given a status in the cited transaction disclosure; it refers generically to “other conditions precedent.” Accordingly, there is no evidentiary basis to state that an MHA clearance is currently pending or is delaying completion. ^[6]
• Shareholder approvals: A media summary refers to other regulatory and shareholder approvals as closing conditions, but does not identify which approvals remain outstanding or provide their status. ^[7]

Assessment: The timeline extension appears primarily driven by the missing CCI clearance, not by a separately evidenced cluster of pending approvals. SEBI’s response effectively converts the timing trigger into a CCI-based trigger rather than granting an unconditional extension: tendering must begin within 12 working days after CCI approval, while payments remain subject to the prescribed 10-working-day period and 10% annual interest for delay. ^[1]

The key uncertainty is whether any additional SPA conditions—potentially including sector-specific or shareholder approvals—remain unresolved. Their existence is acknowledged only in general terms; their identity, filing status and expected completion dates have not been disclosed in the cited material.